The study aimed to assess the role of Pseudomonas aeruginosa (P. aeruginosa) biofilm in the development of antimicrobial resistance of Escherichia coli (E. coli). P. aeruginosa (ATCC 27853) and E. coli (ATCC 25922) were cultured on cetrimide agar and eosin methylene blue (EMB) agar. The two microorganisms were mixed to prepare three bacterial suspensions using tryptic soy broth (TSB) in increasing concentrations, such as: 1:1, 2:3 and 1.5:3.5. Bacterial suspensions were transferred into MBEC™ Assay kits which was subjected to agitation and incubated at 37°C for 24 hrs and 48 hrs. Formed biofilms on peg lids were obtained for Gram staining and cultured using EMB agar to evaluate the biofilm matrix and presence of bacteria. Polymerase chain reaction (PCR) was conducted to determine significant changes in E. coli genes that matched the Tn1696 aacC1, Tn10 tetRA and Tn903 aph resistance genes of E. coli which codes for gentamicin, tetracycline and kanamycin, respectively. Results showed strong bands to Tn1696 aacC1 gene for gentamicin resistance at the highest concentration. No bands were visualized for tetracycline and kanamycin resistance. The results therefore establish that coexistence of both organisms in a biofilm leads to the development of the antimicrobial resistance of E. coli to gentamicin.
An experimental model in Wistar rats, of osteomyelitis caused by Escherichia coli, was used to evaluate the efficacy of cefotaxime in two treatment regimens of different durations. Four groups of rats were set up: a group of rats receiving short-term treatment (14 days) with subcutaneous cefotaxime (100 mg bd), killed after 56 days; a control group receiving no treatment, killed after 56 days; a group of rats undergoing long-term treatment (28 days) with subcutaneous cefotaxime as above, killed after 70 days and a control group of rats receiving no treatment, killed after 70 days. Analysis of histopathological and microbiological findings revealed significantly better results in the long-term treatment group. No side-effects were observed during treatment or afterwards.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.